Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study
- Status
- COMPLETED
- Phase
- PHASE1
Related studies linked through entity extraction aliases.